Literature DB >> 20380545

Is there a relationship between Toxoplasma gondii infection and idiopathic Parkinson's disease?

Tuncay Celik1, Ozden Kamişli, Cahit Babür, Muhammer Ozgür Cevik, Derya Oztuna, Sibel Altinayar.   

Abstract

Idiopathic Parkinson's disease defines a group of Parkinson's disease (PD) of which the aetiology is unknown but an underlying brain disease is suspected. We selected patients of this subgroup of PD and investigated the seropositivity rate for anti-Toxoplasma IgG antibody by Sabin-Feldman dye test (SFDT). By measuring seropositivity in PD patients, we searched for a probable relationship between Toxoplasma gondii infection and idiopathic PD incidence. Fifty patients diagnosed with idiopathic PD and 50 healthy volunteers were included in the study. Blood samples were taken from all 100 participants and anti-T. gondii antibody titres were investigated using SFDT. Anti-T. gondii antibodies were detected at a titre of >or=1/16 in 25 of the 50 patients (50%) and in 20 of the control group (40%). No higher antibody titre was found in the control group. In conclusion, despite the emerging literature on a possible relationship between T. gondii infection and neurological disease, and the high anti-T. gondii seropositivity found in our PD patients, we did not detect any statistically significant association between T. gondii and idiopathic PD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20380545     DOI: 10.3109/00365541003716500

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  19 in total

1.  Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer?

Authors:  Mahmoud Mahami-Oskouei; Faezeh Hamidi; Mahnaz Talebi; Mehdi Farhoudi; Ali Akbar Taheraghdam; Tohid Kazemi; Homayoun Sadeghi-Bazargani; Esmaeil Fallah
Journal:  Parasitol Res       Date:  2016-04-23       Impact factor: 2.289

Review 2.  Toxoplasmosis and neuropsychiatric diseases: can serological studies establish a clear relationship?

Authors:  Silvia Fabiani; Barbara Pinto; Fabrizio Bruschi
Journal:  Neurol Sci       Date:  2012-09-26       Impact factor: 3.307

Review 3.  Toxoplasma gondii infection and behaviour - location, location, location?

Authors:  Glenn A McConkey; Heather L Martin; Greg C Bristow; Joanne P Webster
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

4.  The correlation between Toxoplasma gondii infection and Parkinson's disease: a case-control study.

Authors:  Mahmoud Mahami Oskouei; Faezeh Hamidi; Mahnaz Talebi; Mehdi Farhoudi; Ali Akbar Taheraghdam; Tohid Kazemi; Homayoun Sadeghi-Bazargani; Esmaeil Fallah
Journal:  J Parasit Dis       Date:  2014-10-14

5.  Fatal attraction phenomenon in humans: cat odour attractiveness increased for toxoplasma-infected men while decreased for infected women.

Authors:  Jaroslav Flegr; Pavlína Lenochová; Zdeněk Hodný; Marta Vondrová
Journal:  PLoS Negl Trop Dis       Date:  2011-11-08

6.  Effect of parasitic infection on dopamine biosynthesis in dopaminergic cells.

Authors:  H L Martin; I Alsaady; G Howell; E Prandovszky; C Peers; P Robinson; G A McConkey
Journal:  Neuroscience       Date:  2015-08-20       Impact factor: 3.590

Review 7.  Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Mehdi Sharif; Ahmad Daryani
Journal:  Heliyon       Date:  2021-06-03

8.  Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders.

Authors:  C J Carter
Journal:  J Pathog       Date:  2013-03-04

9.  Toxocara seroprevalence in patients with idiopathic Parkinson's disease: chance association or coincidence?

Authors:  Tuncay Çelik; Yüksel Kaplan; Eser Ataş; Derya Öztuna; Said Berilgen
Journal:  Biomed Res Int       Date:  2012-12-26       Impact factor: 3.411

10.  Latent toxoplasmosis and human.

Authors:  A Dalimi; A Abdoli
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.